nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—CYP2C18—Ifosfamide—hematologic cancer	0.131	0.196	CbGbCtD
Vilazodone—CYP2D6—Lomustine—hematologic cancer	0.0396	0.0593	CbGbCtD
Vilazodone—CYP2D6—Idarubicin—hematologic cancer	0.0353	0.0529	CbGbCtD
Vilazodone—CYP2D6—Hydroxyurea—hematologic cancer	0.03	0.045	CbGbCtD
Vilazodone—CYP3A4—Bexarotene—hematologic cancer	0.0271	0.0406	CbGbCtD
Vilazodone—CYP2D6—Bortezomib—hematologic cancer	0.0261	0.0391	CbGbCtD
Vilazodone—CYP3A4—Busulfan—hematologic cancer	0.0252	0.0377	CbGbCtD
Vilazodone—CYP3A4—Lomustine—hematologic cancer	0.0252	0.0377	CbGbCtD
Vilazodone—CYP3A4—Thiotepa—hematologic cancer	0.0224	0.0336	CbGbCtD
Vilazodone—CYP2D6—Imatinib—hematologic cancer	0.0191	0.0287	CbGbCtD
Vilazodone—CYP3A4—Methoxsalen—hematologic cancer	0.0174	0.0261	CbGbCtD
Vilazodone—CYP2D6—Nilotinib—hematologic cancer	0.0174	0.026	CbGbCtD
Vilazodone—CYP2D6—Vinorelbine—hematologic cancer	0.0172	0.0258	CbGbCtD
Vilazodone—CYP3A4—Bortezomib—hematologic cancer	0.0166	0.0249	CbGbCtD
Vilazodone—CYP3A4—Daunorubicin—hematologic cancer	0.0159	0.0238	CbGbCtD
Vilazodone—CYP3A4—Cytarabine—hematologic cancer	0.014	0.021	CbGbCtD
Vilazodone—CYP3A4—Teniposide—hematologic cancer	0.0138	0.0207	CbGbCtD
Vilazodone—CYP3A4—Ifosfamide—hematologic cancer	0.0127	0.0191	CbGbCtD
Vilazodone—CYP3A4—Imatinib—hematologic cancer	0.0122	0.0182	CbGbCtD
Vilazodone—CYP3A4—Ruxolitinib—hematologic cancer	0.0114	0.0172	CbGbCtD
Vilazodone—CYP3A4—Nilotinib—hematologic cancer	0.011	0.0166	CbGbCtD
Vilazodone—CYP3A4—Vinorelbine—hematologic cancer	0.011	0.0164	CbGbCtD
Vilazodone—CYP2D6—Vinblastine—hematologic cancer	0.0106	0.0159	CbGbCtD
Vilazodone—CYP3A4—Triamcinolone—hematologic cancer	0.01	0.015	CbGbCtD
Vilazodone—CYP3A4—Dasatinib—hematologic cancer	0.00976	0.0146	CbGbCtD
Vilazodone—CYP3A4—Mitoxantrone—hematologic cancer	0.00964	0.0145	CbGbCtD
Vilazodone—CYP3A4—Betamethasone—hematologic cancer	0.00859	0.0129	CbGbCtD
Vilazodone—CYP3A4—Prednisolone—hematologic cancer	0.00848	0.0127	CbGbCtD
Vilazodone—CYP3A4—Prednisone—hematologic cancer	0.00801	0.012	CbGbCtD
Vilazodone—CYP2D6—Dexamethasone—hematologic cancer	0.00786	0.0118	CbGbCtD
Vilazodone—CYP3A4—Irinotecan—hematologic cancer	0.00759	0.0114	CbGbCtD
Vilazodone—CYP3A4—Vinblastine—hematologic cancer	0.00675	0.0101	CbGbCtD
Vilazodone—CYP3A4—Vincristine—hematologic cancer	0.00664	0.00995	CbGbCtD
Vilazodone—CYP2D6—Doxorubicin—hematologic cancer	0.00652	0.00978	CbGbCtD
Vilazodone—CYP3A4—Etoposide—hematologic cancer	0.00608	0.00911	CbGbCtD
Vilazodone—CYP3A4—Dexamethasone—hematologic cancer	0.005	0.00749	CbGbCtD
Vilazodone—CYP3A4—Doxorubicin—hematologic cancer	0.00415	0.00622	CbGbCtD
Vilazodone—Aripiprazole—H1F0—hematologic cancer	0.00266	0.829	CrCbGaD
Vilazodone—Aripiprazole—ABCB1—hematologic cancer	0.000275	0.0857	CrCbGaD
Vilazodone—Trazodone—ABCB1—hematologic cancer	0.000273	0.0853	CrCbGaD
Vilazodone—Hallucination—Prednisone—hematologic cancer	0.000135	0.000474	CcSEcCtD
Vilazodone—Asthenia—Thiotepa—hematologic cancer	0.000134	0.000472	CcSEcCtD
Vilazodone—Diarrhoea—Vinorelbine—hematologic cancer	0.000134	0.000471	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Cisplatin—hematologic cancer	0.000134	0.00047	CcSEcCtD
Vilazodone—Connective tissue disorder—Prednisone—hematologic cancer	0.000133	0.000468	CcSEcCtD
Vilazodone—Nausea—Melphalan—hematologic cancer	0.000133	0.000468	CcSEcCtD
Vilazodone—Feeling abnormal—Mitoxantrone—hematologic cancer	0.000133	0.000468	CcSEcCtD
Vilazodone—Feeling abnormal—Irinotecan—hematologic cancer	0.000133	0.000468	CcSEcCtD
Vilazodone—Dizziness—Bortezomib—hematologic cancer	0.000133	0.000467	CcSEcCtD
Vilazodone—Paraesthesia—Cisplatin—hematologic cancer	0.000132	0.000463	CcSEcCtD
Vilazodone—Skin disorder—Etoposide—hematologic cancer	0.00013	0.000459	CcSEcCtD
Vilazodone—Erectile dysfunction—Methotrexate—hematologic cancer	0.00013	0.000458	CcSEcCtD
Vilazodone—Hyperhidrosis—Etoposide—hematologic cancer	0.00013	0.000457	CcSEcCtD
Vilazodone—Asthenia—Thalidomide—hematologic cancer	0.00013	0.000457	CcSEcCtD
Vilazodone—Feeling abnormal—Gemcitabine—hematologic cancer	0.00013	0.000456	CcSEcCtD
Vilazodone—Dizziness—Vinorelbine—hematologic cancer	0.000129	0.000456	CcSEcCtD
Vilazodone—Nausea—Lenalidomide—hematologic cancer	0.000129	0.000455	CcSEcCtD
Vilazodone—Convulsion—Triamcinolone—hematologic cancer	0.000129	0.000455	CcSEcCtD
Vilazodone—Breast disorder—Doxorubicin—hematologic cancer	0.000128	0.000451	CcSEcCtD
Vilazodone—Hyperhidrosis—Prednisolone—hematologic cancer	0.000128	0.000451	CcSEcCtD
Vilazodone—Diarrhoea—Thiotepa—hematologic cancer	0.000128	0.00045	CcSEcCtD
Vilazodone—Nausea—Hydroxyurea—hematologic cancer	0.000128	0.000449	CcSEcCtD
Vilazodone—Vomiting—Bortezomib—hematologic cancer	0.000127	0.000449	CcSEcCtD
Vilazodone—Decreased appetite—Cisplatin—hematologic cancer	0.000127	0.000448	CcSEcCtD
Vilazodone—Eye disorder—Prednisone—hematologic cancer	0.000127	0.000446	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.000127	0.000445	CcSEcCtD
Vilazodone—Vomiting—Bleomycin—hematologic cancer	0.000127	0.000445	CcSEcCtD
Vilazodone—Asthenia—Carmustine—hematologic cancer	0.000125	0.000438	CcSEcCtD
Vilazodone—Vomiting—Vinorelbine—hematologic cancer	0.000124	0.000438	CcSEcCtD
Vilazodone—Dry mouth—Triamcinolone—hematologic cancer	0.000124	0.000437	CcSEcCtD
Vilazodone—Diarrhoea—Thalidomide—hematologic cancer	0.000124	0.000435	CcSEcCtD
Vilazodone—Dizziness—Thiotepa—hematologic cancer	0.000124	0.000435	CcSEcCtD
Vilazodone—Asthenia—Alitretinoin—hematologic cancer	0.000123	0.000434	CcSEcCtD
Vilazodone—Pollakiuria—Epirubicin—hematologic cancer	0.000122	0.00043	CcSEcCtD
Vilazodone—Asthenia—Ifosfamide—hematologic cancer	0.000122	0.000429	CcSEcCtD
Vilazodone—Feeling abnormal—Cisplatin—hematologic cancer	0.000121	0.000425	CcSEcCtD
Vilazodone—Paraesthesia—Etoposide—hematologic cancer	0.000121	0.000424	CcSEcCtD
Vilazodone—Insomnia—Prednisolone—hematologic cancer	0.00012	0.000422	CcSEcCtD
Vilazodone—Dizziness—Thalidomide—hematologic cancer	0.00012	0.000421	CcSEcCtD
Vilazodone—Somnolence—Etoposide—hematologic cancer	0.000119	0.00042	CcSEcCtD
Vilazodone—Nausea—Bortezomib—hematologic cancer	0.000119	0.000419	CcSEcCtD
Vilazodone—Asthenia—Vincristine—hematologic cancer	0.000119	0.000419	CcSEcCtD
Vilazodone—Paraesthesia—Prednisolone—hematologic cancer	0.000119	0.000419	CcSEcCtD
Vilazodone—Vomiting—Thiotepa—hematologic cancer	0.000119	0.000418	CcSEcCtD
Vilazodone—Diarrhoea—Carmustine—hematologic cancer	0.000119	0.000418	CcSEcCtD
Vilazodone—Mental disorder—Prednisone—hematologic cancer	0.000119	0.000418	CcSEcCtD
Vilazodone—Nausea—Bleomycin—hematologic cancer	0.000118	0.000416	CcSEcCtD
Vilazodone—Malnutrition—Prednisone—hematologic cancer	0.000118	0.000415	CcSEcCtD
Vilazodone—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000118	0.000414	CcSEcCtD
Vilazodone—Diarrhoea—Alitretinoin—hematologic cancer	0.000118	0.000414	CcSEcCtD
Vilazodone—Convulsion—Betamethasone—hematologic cancer	0.000117	0.000413	CcSEcCtD
Vilazodone—Convulsion—Dexamethasone—hematologic cancer	0.000117	0.000413	CcSEcCtD
Vilazodone—Decreased appetite—Etoposide—hematologic cancer	0.000117	0.000411	CcSEcCtD
Vilazodone—Diarrhoea—Ifosfamide—hematologic cancer	0.000116	0.000409	CcSEcCtD
Vilazodone—Nausea—Vinorelbine—hematologic cancer	0.000116	0.000409	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000116	0.000408	CcSEcCtD
Vilazodone—Asthenia—Irinotecan—hematologic cancer	0.000116	0.000408	CcSEcCtD
Vilazodone—Asthenia—Mitoxantrone—hematologic cancer	0.000116	0.000408	CcSEcCtD
Vilazodone—Fatigue—Etoposide—hematologic cancer	0.000116	0.000407	CcSEcCtD
Vilazodone—Vomiting—Thalidomide—hematologic cancer	0.000115	0.000405	CcSEcCtD
Vilazodone—Dizziness—Carmustine—hematologic cancer	0.000115	0.000404	CcSEcCtD
Vilazodone—Dizziness—Alitretinoin—hematologic cancer	0.000114	0.0004	CcSEcCtD
Vilazodone—Diarrhoea—Vincristine—hematologic cancer	0.000113	0.000399	CcSEcCtD
Vilazodone—Pollakiuria—Doxorubicin—hematologic cancer	0.000113	0.000398	CcSEcCtD
Vilazodone—Asthenia—Gemcitabine—hematologic cancer	0.000113	0.000397	CcSEcCtD
Vilazodone—Dizziness—Ifosfamide—hematologic cancer	0.000112	0.000396	CcSEcCtD
Vilazodone—Vision blurred—Prednisone—hematologic cancer	0.000111	0.000391	CcSEcCtD
Vilazodone—Nausea—Thiotepa—hematologic cancer	0.000111	0.000391	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000111	0.000391	CcSEcCtD
Vilazodone—Feeling abnormal—Etoposide—hematologic cancer	0.000111	0.000389	CcSEcCtD
Vilazodone—Diarrhoea—Irinotecan—hematologic cancer	0.00011	0.000389	CcSEcCtD
Vilazodone—Diarrhoea—Mitoxantrone—hematologic cancer	0.00011	0.000389	CcSEcCtD
Vilazodone—Vomiting—Carmustine—hematologic cancer	0.00011	0.000389	CcSEcCtD
Vilazodone—Insomnia—Triamcinolone—hematologic cancer	0.00011	0.000388	CcSEcCtD
Vilazodone—Dizziness—Vincristine—hematologic cancer	0.00011	0.000386	CcSEcCtD
Vilazodone—Vomiting—Alitretinoin—hematologic cancer	0.000109	0.000385	CcSEcCtD
Vilazodone—Paraesthesia—Triamcinolone—hematologic cancer	0.000109	0.000385	CcSEcCtD
Vilazodone—Feeling abnormal—Prednisolone—hematologic cancer	0.000109	0.000384	CcSEcCtD
Vilazodone—Nervous system disorder—Dexamethasone—hematologic cancer	0.000108	0.000381	CcSEcCtD
Vilazodone—Nervous system disorder—Betamethasone—hematologic cancer	0.000108	0.000381	CcSEcCtD
Vilazodone—Agitation—Prednisone—hematologic cancer	0.000108	0.000381	CcSEcCtD
Vilazodone—Vomiting—Ifosfamide—hematologic cancer	0.000108	0.00038	CcSEcCtD
Vilazodone—Diarrhoea—Gemcitabine—hematologic cancer	0.000108	0.000379	CcSEcCtD
Vilazodone—Nausea—Thalidomide—hematologic cancer	0.000107	0.000378	CcSEcCtD
Vilazodone—Dyspepsia—Triamcinolone—hematologic cancer	0.000107	0.000377	CcSEcCtD
Vilazodone—Hyperhidrosis—Betamethasone—hematologic cancer	0.000107	0.000376	CcSEcCtD
Vilazodone—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000107	0.000376	CcSEcCtD
Vilazodone—Dizziness—Irinotecan—hematologic cancer	0.000107	0.000376	CcSEcCtD
Vilazodone—Eye disorder—Methotrexate—hematologic cancer	0.000106	0.000372	CcSEcCtD
Vilazodone—Vomiting—Vincristine—hematologic cancer	0.000105	0.000371	CcSEcCtD
Vilazodone—Asthenia—Cisplatin—hematologic cancer	0.000105	0.00037	CcSEcCtD
Vilazodone—Cardiac disorder—Methotrexate—hematologic cancer	0.000105	0.00037	CcSEcCtD
Vilazodone—Fatigue—Triamcinolone—hematologic cancer	0.000105	0.00037	CcSEcCtD
Vilazodone—Connective tissue disorder—Epirubicin—hematologic cancer	0.000104	0.000366	CcSEcCtD
Vilazodone—Nausea—Carmustine—hematologic cancer	0.000103	0.000363	CcSEcCtD
Vilazodone—Vomiting—Irinotecan—hematologic cancer	0.000103	0.000361	CcSEcCtD
Vilazodone—Vomiting—Mitoxantrone—hematologic cancer	0.000103	0.000361	CcSEcCtD
Vilazodone—Nausea—Alitretinoin—hematologic cancer	0.000102	0.00036	CcSEcCtD
Vilazodone—Convulsion—Prednisone—hematologic cancer	0.000102	0.00036	CcSEcCtD
Vilazodone—Nausea—Ifosfamide—hematologic cancer	0.000101	0.000355	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000101	0.000354	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000101	0.000354	CcSEcCtD
Vilazodone—Arthralgia—Prednisone—hematologic cancer	0.0001	0.000353	CcSEcCtD
Vilazodone—Feeling abnormal—Triamcinolone—hematologic cancer	0.0001	0.000353	CcSEcCtD
Vilazodone—Diarrhoea—Cisplatin—hematologic cancer	0.0001	0.000353	CcSEcCtD
Vilazodone—Vomiting—Gemcitabine—hematologic cancer	0.0001	0.000352	CcSEcCtD
Vilazodone—Insomnia—Dexamethasone—hematologic cancer	0.0001	0.000352	CcSEcCtD
Vilazodone—Insomnia—Betamethasone—hematologic cancer	0.0001	0.000352	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	9.97e-05	0.000351	CcSEcCtD
Vilazodone—Paraesthesia—Dexamethasone—hematologic cancer	9.93e-05	0.000349	CcSEcCtD
Vilazodone—Paraesthesia—Betamethasone—hematologic cancer	9.93e-05	0.000349	CcSEcCtD
Vilazodone—Mental disorder—Methotrexate—hematologic cancer	9.92e-05	0.000349	CcSEcCtD
Vilazodone—Eye disorder—Epirubicin—hematologic cancer	9.9e-05	0.000348	CcSEcCtD
Vilazodone—Malnutrition—Methotrexate—hematologic cancer	9.86e-05	0.000347	CcSEcCtD
Vilazodone—Nausea—Vincristine—hematologic cancer	9.85e-05	0.000347	CcSEcCtD
Vilazodone—Cardiac disorder—Epirubicin—hematologic cancer	9.83e-05	0.000346	CcSEcCtD
Vilazodone—Dyspepsia—Betamethasone—hematologic cancer	9.73e-05	0.000342	CcSEcCtD
Vilazodone—Dyspepsia—Dexamethasone—hematologic cancer	9.73e-05	0.000342	CcSEcCtD
Vilazodone—Dysgeusia—Methotrexate—hematologic cancer	9.65e-05	0.00034	CcSEcCtD
Vilazodone—Asthenia—Etoposide—hematologic cancer	9.64e-05	0.000339	CcSEcCtD
Vilazodone—Connective tissue disorder—Doxorubicin—hematologic cancer	9.64e-05	0.000339	CcSEcCtD
Vilazodone—Decreased appetite—Betamethasone—hematologic cancer	9.61e-05	0.000338	CcSEcCtD
Vilazodone—Decreased appetite—Dexamethasone—hematologic cancer	9.61e-05	0.000338	CcSEcCtD
Vilazodone—Nausea—Mitoxantrone—hematologic cancer	9.59e-05	0.000337	CcSEcCtD
Vilazodone—Nausea—Irinotecan—hematologic cancer	9.59e-05	0.000337	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	9.54e-05	0.000336	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Betamethasone—hematologic cancer	9.54e-05	0.000336	CcSEcCtD
Vilazodone—Fatigue—Betamethasone—hematologic cancer	9.53e-05	0.000335	CcSEcCtD
Vilazodone—Fatigue—Dexamethasone—hematologic cancer	9.53e-05	0.000335	CcSEcCtD
Vilazodone—Nervous system disorder—Prednisone—hematologic cancer	9.44e-05	0.000332	CcSEcCtD
Vilazodone—Skin disorder—Prednisone—hematologic cancer	9.35e-05	0.000329	CcSEcCtD
Vilazodone—Nausea—Gemcitabine—hematologic cancer	9.34e-05	0.000329	CcSEcCtD
Vilazodone—Vomiting—Cisplatin—hematologic cancer	9.32e-05	0.000328	CcSEcCtD
Vilazodone—Hyperhidrosis—Prednisone—hematologic cancer	9.31e-05	0.000327	CcSEcCtD
Vilazodone—Vision blurred—Methotrexate—hematologic cancer	9.29e-05	0.000327	CcSEcCtD
Vilazodone—Mental disorder—Epirubicin—hematologic cancer	9.28e-05	0.000327	CcSEcCtD
Vilazodone—Malnutrition—Epirubicin—hematologic cancer	9.22e-05	0.000325	CcSEcCtD
Vilazodone—Diarrhoea—Etoposide—hematologic cancer	9.19e-05	0.000323	CcSEcCtD
Vilazodone—Eye disorder—Doxorubicin—hematologic cancer	9.16e-05	0.000322	CcSEcCtD
Vilazodone—Feeling abnormal—Betamethasone—hematologic cancer	9.11e-05	0.00032	CcSEcCtD
Vilazodone—Feeling abnormal—Dexamethasone—hematologic cancer	9.11e-05	0.00032	CcSEcCtD
Vilazodone—Cardiac disorder—Doxorubicin—hematologic cancer	9.1e-05	0.00032	CcSEcCtD
Vilazodone—Flatulence—Epirubicin—hematologic cancer	9.09e-05	0.00032	CcSEcCtD
Vilazodone—Dysgeusia—Epirubicin—hematologic cancer	9.03e-05	0.000318	CcSEcCtD
Vilazodone—Nervousness—Epirubicin—hematologic cancer	8.96e-05	0.000315	CcSEcCtD
Vilazodone—Dizziness—Etoposide—hematologic cancer	8.88e-05	0.000312	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Prednisone—hematologic cancer	8.77e-05	0.000309	CcSEcCtD
Vilazodone—Dizziness—Prednisolone—hematologic cancer	8.76e-05	0.000308	CcSEcCtD
Vilazodone—Asthenia—Triamcinolone—hematologic cancer	8.74e-05	0.000308	CcSEcCtD
Vilazodone—Nausea—Cisplatin—hematologic cancer	8.71e-05	0.000306	CcSEcCtD
Vilazodone—Insomnia—Prednisone—hematologic cancer	8.71e-05	0.000306	CcSEcCtD
Vilazodone—Vision blurred—Epirubicin—hematologic cancer	8.69e-05	0.000306	CcSEcCtD
Vilazodone—Paraesthesia—Prednisone—hematologic cancer	8.64e-05	0.000304	CcSEcCtD
Vilazodone—Mental disorder—Doxorubicin—hematologic cancer	8.59e-05	0.000302	CcSEcCtD
Vilazodone—Convulsion—Methotrexate—hematologic cancer	8.54e-05	0.000301	CcSEcCtD
Vilazodone—Vomiting—Etoposide—hematologic cancer	8.54e-05	0.0003	CcSEcCtD
Vilazodone—Malnutrition—Doxorubicin—hematologic cancer	8.54e-05	0.0003	CcSEcCtD
Vilazodone—Agitation—Epirubicin—hematologic cancer	8.48e-05	0.000298	CcSEcCtD
Vilazodone—Dyspepsia—Prednisone—hematologic cancer	8.47e-05	0.000298	CcSEcCtD
Vilazodone—Flatulence—Doxorubicin—hematologic cancer	8.41e-05	0.000296	CcSEcCtD
Vilazodone—Arthralgia—Methotrexate—hematologic cancer	8.39e-05	0.000295	CcSEcCtD
Vilazodone—Decreased appetite—Prednisone—hematologic cancer	8.37e-05	0.000294	CcSEcCtD
Vilazodone—Dysgeusia—Doxorubicin—hematologic cancer	8.36e-05	0.000294	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	8.33e-05	0.000293	CcSEcCtD
Vilazodone—Fatigue—Prednisone—hematologic cancer	8.3e-05	0.000292	CcSEcCtD
Vilazodone—Nervousness—Doxorubicin—hematologic cancer	8.29e-05	0.000292	CcSEcCtD
Vilazodone—Palpitations—Epirubicin—hematologic cancer	8.15e-05	0.000287	CcSEcCtD
Vilazodone—Dizziness—Triamcinolone—hematologic cancer	8.06e-05	0.000283	CcSEcCtD
Vilazodone—Vision blurred—Doxorubicin—hematologic cancer	8.04e-05	0.000283	CcSEcCtD
Vilazodone—Convulsion—Epirubicin—hematologic cancer	7.99e-05	0.000281	CcSEcCtD
Vilazodone—Nausea—Etoposide—hematologic cancer	7.98e-05	0.000281	CcSEcCtD
Vilazodone—Feeling abnormal—Prednisone—hematologic cancer	7.93e-05	0.000279	CcSEcCtD
Vilazodone—Asthenia—Betamethasone—hematologic cancer	7.93e-05	0.000279	CcSEcCtD
Vilazodone—Asthenia—Dexamethasone—hematologic cancer	7.93e-05	0.000279	CcSEcCtD
Vilazodone—Nervous system disorder—Methotrexate—hematologic cancer	7.89e-05	0.000278	CcSEcCtD
Vilazodone—Nausea—Prednisolone—hematologic cancer	7.87e-05	0.000277	CcSEcCtD
Vilazodone—Arthralgia—Epirubicin—hematologic cancer	7.85e-05	0.000276	CcSEcCtD
Vilazodone—Agitation—Doxorubicin—hematologic cancer	7.84e-05	0.000276	CcSEcCtD
Vilazodone—Skin disorder—Methotrexate—hematologic cancer	7.81e-05	0.000275	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	7.8e-05	0.000274	CcSEcCtD
Vilazodone—Hyperhidrosis—Methotrexate—hematologic cancer	7.78e-05	0.000274	CcSEcCtD
Vilazodone—Vomiting—Triamcinolone—hematologic cancer	7.75e-05	0.000273	CcSEcCtD
Vilazodone—Dry mouth—Epirubicin—hematologic cancer	7.68e-05	0.00027	CcSEcCtD
Vilazodone—Diarrhoea—Betamethasone—hematologic cancer	7.56e-05	0.000266	CcSEcCtD
Vilazodone—Diarrhoea—Dexamethasone—hematologic cancer	7.56e-05	0.000266	CcSEcCtD
Vilazodone—Palpitations—Doxorubicin—hematologic cancer	7.54e-05	0.000265	CcSEcCtD
Vilazodone—Convulsion—Doxorubicin—hematologic cancer	7.4e-05	0.00026	CcSEcCtD
Vilazodone—Nervous system disorder—Epirubicin—hematologic cancer	7.38e-05	0.00026	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	7.33e-05	0.000258	CcSEcCtD
Vilazodone—Skin disorder—Epirubicin—hematologic cancer	7.31e-05	0.000257	CcSEcCtD
Vilazodone—Dizziness—Dexamethasone—hematologic cancer	7.31e-05	0.000257	CcSEcCtD
Vilazodone—Dizziness—Betamethasone—hematologic cancer	7.31e-05	0.000257	CcSEcCtD
Vilazodone—Hyperhidrosis—Epirubicin—hematologic cancer	7.28e-05	0.000256	CcSEcCtD
Vilazodone—Insomnia—Methotrexate—hematologic cancer	7.28e-05	0.000256	CcSEcCtD
Vilazodone—Arthralgia—Doxorubicin—hematologic cancer	7.27e-05	0.000256	CcSEcCtD
Vilazodone—Nausea—Triamcinolone—hematologic cancer	7.24e-05	0.000255	CcSEcCtD
Vilazodone—Paraesthesia—Methotrexate—hematologic cancer	7.22e-05	0.000254	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	7.22e-05	0.000254	CcSEcCtD
Vilazodone—Somnolence—Methotrexate—hematologic cancer	7.15e-05	0.000252	CcSEcCtD
Vilazodone—Dry mouth—Doxorubicin—hematologic cancer	7.11e-05	0.00025	CcSEcCtD
Vilazodone—Dyspepsia—Methotrexate—hematologic cancer	7.08e-05	0.000249	CcSEcCtD
Vilazodone—Vomiting—Betamethasone—hematologic cancer	7.03e-05	0.000247	CcSEcCtD
Vilazodone—Vomiting—Dexamethasone—hematologic cancer	7.03e-05	0.000247	CcSEcCtD
Vilazodone—Decreased appetite—Methotrexate—hematologic cancer	6.99e-05	0.000246	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.95e-05	0.000244	CcSEcCtD
Vilazodone—Fatigue—Methotrexate—hematologic cancer	6.94e-05	0.000244	CcSEcCtD
Vilazodone—Asthenia—Prednisone—hematologic cancer	6.91e-05	0.000243	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	6.86e-05	0.000241	CcSEcCtD
Vilazodone—Nervous system disorder—Doxorubicin—hematologic cancer	6.83e-05	0.00024	CcSEcCtD
Vilazodone—Insomnia—Epirubicin—hematologic cancer	6.81e-05	0.00024	CcSEcCtD
Vilazodone—Skin disorder—Doxorubicin—hematologic cancer	6.77e-05	0.000238	CcSEcCtD
Vilazodone—Paraesthesia—Epirubicin—hematologic cancer	6.76e-05	0.000238	CcSEcCtD
Vilazodone—Hyperhidrosis—Doxorubicin—hematologic cancer	6.73e-05	0.000237	CcSEcCtD
Vilazodone—Somnolence—Epirubicin—hematologic cancer	6.69e-05	0.000235	CcSEcCtD
Vilazodone—Feeling abnormal—Methotrexate—hematologic cancer	6.63e-05	0.000233	CcSEcCtD
Vilazodone—Dyspepsia—Epirubicin—hematologic cancer	6.63e-05	0.000233	CcSEcCtD
Vilazodone—Diarrhoea—Prednisone—hematologic cancer	6.59e-05	0.000232	CcSEcCtD
Vilazodone—Nausea—Dexamethasone—hematologic cancer	6.57e-05	0.000231	CcSEcCtD
Vilazodone—Nausea—Betamethasone—hematologic cancer	6.57e-05	0.000231	CcSEcCtD
Vilazodone—Decreased appetite—Epirubicin—hematologic cancer	6.54e-05	0.00023	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Epirubicin—hematologic cancer	6.5e-05	0.000229	CcSEcCtD
Vilazodone—Fatigue—Epirubicin—hematologic cancer	6.49e-05	0.000228	CcSEcCtD
Vilazodone—Dizziness—Prednisone—hematologic cancer	6.37e-05	0.000224	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	6.35e-05	0.000223	CcSEcCtD
Vilazodone—Insomnia—Doxorubicin—hematologic cancer	6.3e-05	0.000222	CcSEcCtD
Vilazodone—Paraesthesia—Doxorubicin—hematologic cancer	6.26e-05	0.00022	CcSEcCtD
Vilazodone—Feeling abnormal—Epirubicin—hematologic cancer	6.2e-05	0.000218	CcSEcCtD
Vilazodone—Somnolence—Doxorubicin—hematologic cancer	6.19e-05	0.000218	CcSEcCtD
Vilazodone—Dyspepsia—Doxorubicin—hematologic cancer	6.13e-05	0.000216	CcSEcCtD
Vilazodone—Vomiting—Prednisone—hematologic cancer	6.12e-05	0.000215	CcSEcCtD
Vilazodone—Decreased appetite—Doxorubicin—hematologic cancer	6.06e-05	0.000213	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	6.01e-05	0.000212	CcSEcCtD
Vilazodone—Fatigue—Doxorubicin—hematologic cancer	6.01e-05	0.000211	CcSEcCtD
Vilazodone—Asthenia—Methotrexate—hematologic cancer	5.77e-05	0.000203	CcSEcCtD
Vilazodone—Feeling abnormal—Doxorubicin—hematologic cancer	5.74e-05	0.000202	CcSEcCtD
Vilazodone—Nausea—Prednisone—hematologic cancer	5.72e-05	0.000201	CcSEcCtD
Vilazodone—Diarrhoea—Methotrexate—hematologic cancer	5.5e-05	0.000194	CcSEcCtD
Vilazodone—Asthenia—Epirubicin—hematologic cancer	5.4e-05	0.00019	CcSEcCtD
Vilazodone—Dizziness—Methotrexate—hematologic cancer	5.32e-05	0.000187	CcSEcCtD
Vilazodone—Diarrhoea—Epirubicin—hematologic cancer	5.15e-05	0.000181	CcSEcCtD
Vilazodone—Vomiting—Methotrexate—hematologic cancer	5.12e-05	0.00018	CcSEcCtD
Vilazodone—Asthenia—Doxorubicin—hematologic cancer	5e-05	0.000176	CcSEcCtD
Vilazodone—Dizziness—Epirubicin—hematologic cancer	4.98e-05	0.000175	CcSEcCtD
Vilazodone—Vomiting—Epirubicin—hematologic cancer	4.79e-05	0.000168	CcSEcCtD
Vilazodone—Nausea—Methotrexate—hematologic cancer	4.78e-05	0.000168	CcSEcCtD
Vilazodone—Diarrhoea—Doxorubicin—hematologic cancer	4.77e-05	0.000168	CcSEcCtD
Vilazodone—Dizziness—Doxorubicin—hematologic cancer	4.61e-05	0.000162	CcSEcCtD
Vilazodone—Nausea—Epirubicin—hematologic cancer	4.47e-05	0.000157	CcSEcCtD
Vilazodone—Vomiting—Doxorubicin—hematologic cancer	4.43e-05	0.000156	CcSEcCtD
Vilazodone—Nausea—Doxorubicin—hematologic cancer	4.14e-05	0.000146	CcSEcCtD
Vilazodone—DRD2—Signaling Pathways—PTPN1—hematologic cancer	9.34e-06	0.000205	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KITLG—hematologic cancer	9.26e-06	0.000204	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PTPN11—hematologic cancer	9.22e-06	0.000203	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RASGRP1—hematologic cancer	9.19e-06	0.000202	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HSP90AA1—hematologic cancer	9.16e-06	0.000201	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SYK—hematologic cancer	9.16e-06	0.000201	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NUP98—hematologic cancer	9.11e-06	0.0002	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CD—hematologic cancer	9.09e-06	0.0002	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—STAT5A—hematologic cancer	9.05e-06	0.000199	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CB—hematologic cancer	9.02e-06	0.000198	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDKN2B—hematologic cancer	8.97e-06	0.000197	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CREB1—hematologic cancer	8.94e-06	0.000196	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3R1—hematologic cancer	8.88e-06	0.000195	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ADCY7—hematologic cancer	8.84e-06	0.000194	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NCOA3—hematologic cancer	8.84e-06	0.000194	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—STAT1—hematologic cancer	8.83e-06	0.000194	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NUP214—hematologic cancer	8.78e-06	0.000193	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CCL2—hematologic cancer	8.74e-06	0.000192	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—FHL2—hematologic cancer	8.72e-06	0.000192	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6R—hematologic cancer	8.72e-06	0.000192	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CB—hematologic cancer	8.67e-06	0.000191	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CD86—hematologic cancer	8.67e-06	0.000191	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—JAK2—hematologic cancer	8.63e-06	0.00019	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MTR—hematologic cancer	8.6e-06	0.000189	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ABCG2—hematologic cancer	8.6e-06	0.000189	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3R1—hematologic cancer	8.58e-06	0.000189	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AGRN—hematologic cancer	8.56e-06	0.000188	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HES1—hematologic cancer	8.55e-06	0.000188	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NCOR1—hematologic cancer	8.51e-06	0.000187	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ENO2—hematologic cancer	8.43e-06	0.000185	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGF1—hematologic cancer	8.41e-06	0.000185	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CSF2—hematologic cancer	8.41e-06	0.000185	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—JAK2—hematologic cancer	8.34e-06	0.000183	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—MAP2K1—hematologic cancer	8.31e-06	0.000183	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FOXO1—hematologic cancer	8.29e-06	0.000182	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—IL2—hematologic cancer	8.29e-06	0.000182	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PDGFRB—hematologic cancer	8.27e-06	0.000182	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GRB2—hematologic cancer	8.26e-06	0.000182	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CD—hematologic cancer	8.25e-06	0.000181	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PDGFA—hematologic cancer	8.24e-06	0.000181	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CB—hematologic cancer	8.19e-06	0.00018	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTT1—hematologic cancer	8.18e-06	0.00018	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PDGFRA—hematologic cancer	8.15e-06	0.000179	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KITLG—hematologic cancer	8.13e-06	0.000179	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—JAK1—hematologic cancer	8.12e-06	0.000178	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRKCG—hematologic cancer	8.12e-06	0.000178	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HMMR—hematologic cancer	8.11e-06	0.000178	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—IDH2—hematologic cancer	8.11e-06	0.000178	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SDC1—hematologic cancer	7.99e-06	0.000176	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—STAT5A—hematologic cancer	7.94e-06	0.000175	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CB—hematologic cancer	7.92e-06	0.000174	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDKN2B—hematologic cancer	7.87e-06	0.000173	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3R1—hematologic cancer	7.79e-06	0.000171	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ARNTL—hematologic cancer	7.63e-06	0.000168	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CD86—hematologic cancer	7.62e-06	0.000167	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL2RA—hematologic cancer	7.58e-06	0.000167	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—JAK2—hematologic cancer	7.57e-06	0.000167	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL2—hematologic cancer	7.52e-06	0.000165	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HES1—hematologic cancer	7.51e-06	0.000165	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TERT—hematologic cancer	7.5e-06	0.000165	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PTEN—hematologic cancer	7.5e-06	0.000165	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NCOR1—hematologic cancer	7.47e-06	0.000164	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CA9—hematologic cancer	7.42e-06	0.000163	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ACP5—hematologic cancer	7.42e-06	0.000163	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CSF2—hematologic cancer	7.38e-06	0.000162	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGF1—hematologic cancer	7.38e-06	0.000162	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NCOR2—hematologic cancer	7.32e-06	0.000161	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PDGFB—hematologic cancer	7.32e-06	0.000161	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FOXO1—hematologic cancer	7.28e-06	0.00016	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—IL2—hematologic cancer	7.27e-06	0.00016	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PDGFRB—hematologic cancer	7.26e-06	0.00016	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CB—hematologic cancer	7.19e-06	0.000158	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PDGFRA—hematologic cancer	7.15e-06	0.000157	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TSC2—hematologic cancer	7.15e-06	0.000157	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—EP300—hematologic cancer	7.15e-06	0.000157	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRKCG—hematologic cancer	7.13e-06	0.000157	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—JAK1—hematologic cancer	7.13e-06	0.000157	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—IDH1—hematologic cancer	6.97e-06	0.000153	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ABCC3—hematologic cancer	6.9e-06	0.000152	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TXN—hematologic cancer	6.9e-06	0.000152	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTO1—hematologic cancer	6.9e-06	0.000152	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGFR3—hematologic cancer	6.88e-06	0.000151	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK14—hematologic cancer	6.81e-06	0.00015	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NQO1—hematologic cancer	6.8e-06	0.000149	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CD44—hematologic cancer	6.8e-06	0.000149	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SPHK1—hematologic cancer	6.75e-06	0.000148	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ESR1—hematologic cancer	6.68e-06	0.000147	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL2RA—hematologic cancer	6.66e-06	0.000146	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL2—hematologic cancer	6.61e-06	0.000145	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FN1—hematologic cancer	6.6e-06	0.000145	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TERT—hematologic cancer	6.58e-06	0.000145	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—BAD—hematologic cancer	6.52e-06	0.000143	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NFKBIA—hematologic cancer	6.52e-06	0.000143	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	6.48e-06	0.000143	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NOTCH1—hematologic cancer	6.46e-06	0.000142	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYCS—hematologic cancer	6.43e-06	0.000141	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PDGFB—hematologic cancer	6.42e-06	0.000141	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	6.39e-06	0.000141	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CD80—hematologic cancer	6.33e-06	0.000139	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CG—hematologic cancer	6.32e-06	0.000139	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KIT—hematologic cancer	6.32e-06	0.000139	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—NRAS—hematologic cancer	6.32e-06	0.000139	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.31e-06	0.000139	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.31e-06	0.000139	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TSC2—hematologic cancer	6.28e-06	0.000138	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PTPN11—hematologic cancer	6.21e-06	0.000136	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.15e-06	0.000135	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—MAPK3—hematologic cancer	6.05e-06	0.000133	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGFR3—hematologic cancer	6.04e-06	0.000133	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CREB1—hematologic cancer	6.01e-06	0.000132	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK14—hematologic cancer	5.98e-06	0.000131	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NUP98—hematologic cancer	5.95e-06	0.000131	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—BRAF—hematologic cancer	5.94e-06	0.000131	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCL2—hematologic cancer	5.88e-06	0.000129	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ESR1—hematologic cancer	5.87e-06	0.000129	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6R—hematologic cancer	5.86e-06	0.000129	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CREBBP—hematologic cancer	5.86e-06	0.000129	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FN1—hematologic cancer	5.79e-06	0.000127	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ADCY7—hematologic cancer	5.78e-06	0.000127	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NCOA3—hematologic cancer	5.78e-06	0.000127	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NUP214—hematologic cancer	5.74e-06	0.000126	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NFKBIA—hematologic cancer	5.73e-06	0.000126	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—BAD—hematologic cancer	5.73e-06	0.000126	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NOTCH1—hematologic cancer	5.67e-06	0.000125	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTP1—hematologic cancer	5.67e-06	0.000125	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.62e-06	0.000124	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MTR—hematologic cancer	5.62e-06	0.000124	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAP2K1—hematologic cancer	5.59e-06	0.000123	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CD80—hematologic cancer	5.56e-06	0.000122	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CD—hematologic cancer	5.55e-06	0.000122	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CG—hematologic cancer	5.55e-06	0.000122	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KIT—hematologic cancer	5.55e-06	0.000122	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—NRAS—hematologic cancer	5.55e-06	0.000122	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ENO2—hematologic cancer	5.51e-06	0.000121	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	5.5e-06	0.000121	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PTPN11—hematologic cancer	5.45e-06	0.00012	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—KRAS—hematologic cancer	5.44e-06	0.00012	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ABCB1—hematologic cancer	5.37e-06	0.000118	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.35e-06	0.000118	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGF2—hematologic cancer	5.32e-06	0.000117	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—MAPK3—hematologic cancer	5.31e-06	0.000117	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CA—hematologic cancer	5.29e-06	0.000116	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CREB1—hematologic cancer	5.28e-06	0.000116	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3R1—hematologic cancer	5.24e-06	0.000115	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SDC1—hematologic cancer	5.23e-06	0.000115	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—BRAF—hematologic cancer	5.21e-06	0.000115	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NCOR1—hematologic cancer	5.21e-06	0.000115	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTM1—hematologic cancer	5.21e-06	0.000115	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCL2—hematologic cancer	5.16e-06	0.000114	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6R—hematologic cancer	5.15e-06	0.000113	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CREBBP—hematologic cancer	5.14e-06	0.000113	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—JAK2—hematologic cancer	5.1e-06	0.000112	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CA—hematologic cancer	4.99e-06	0.00011	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MDM2—hematologic cancer	4.97e-06	0.000109	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAP2K1—hematologic cancer	4.91e-06	0.000108	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CD—hematologic cancer	4.87e-06	0.000107	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CB—hematologic cancer	4.84e-06	0.000106	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MTOR—hematologic cancer	4.84e-06	0.000106	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CA—hematologic cancer	4.83e-06	0.000106	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—KRAS—hematologic cancer	4.77e-06	0.000105	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGF2—hematologic cancer	4.67e-06	0.000103	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HRAS—hematologic cancer	4.62e-06	0.000102	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MTHFR—hematologic cancer	4.6e-06	0.000101	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	4.6e-06	0.000101	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	4.54e-06	9.99e-05	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	4.49e-06	9.88e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—JAK2—hematologic cancer	4.47e-06	9.84e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CASP3—hematologic cancer	4.45e-06	9.79e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL2—hematologic cancer	4.44e-06	9.77e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NQO1—hematologic cancer	4.44e-06	9.77e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CD44—hematologic cancer	4.44e-06	9.77e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL6—hematologic cancer	4.42e-06	9.72e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	4.38e-06	9.64e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MDM2—hematologic cancer	4.37e-06	9.6e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCND1—hematologic cancer	4.33e-06	9.53e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—JUN—hematologic cancer	4.32e-06	9.51e-05	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—AKT1—hematologic cancer	4.32e-06	9.5e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MTOR—hematologic cancer	4.25e-06	9.34e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	4.25e-06	9.34e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYCS—hematologic cancer	4.21e-06	9.25e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	4.19e-06	9.22e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PTEN—hematologic cancer	4.18e-06	9.2e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.18e-06	9.19e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	4.09e-06	9e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	4.08e-06	8.97e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HRAS—hematologic cancer	4.06e-06	8.92e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—EP300—hematologic cancer	3.99e-06	8.77e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	3.99e-06	8.77e-05	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	3.94e-06	8.67e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CASP3—hematologic cancer	3.91e-06	8.59e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL2—hematologic cancer	3.9e-06	8.58e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6—hematologic cancer	3.88e-06	8.54e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SRC—hematologic cancer	3.88e-06	8.53e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.87e-06	8.51e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCND1—hematologic cancer	3.8e-06	8.36e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—JUN—hematologic cancer	3.8e-06	8.35e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	3.78e-06	8.31e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—STAT3—hematologic cancer	3.74e-06	8.22e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NRAS—hematologic cancer	3.73e-06	8.2e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.71e-06	8.15e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	3.68e-06	8.09e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PTEN—hematologic cancer	3.67e-06	8.07e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK8—hematologic cancer	3.59e-06	7.9e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.59e-06	7.89e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AKT1—hematologic cancer	3.58e-06	7.88e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	3.57e-06	7.86e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.51e-06	7.71e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EP300—hematologic cancer	3.5e-06	7.7e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MYC—hematologic cancer	3.48e-06	7.64e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	3.47e-06	7.62e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.41e-06	7.49e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.41e-06	7.49e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SRC—hematologic cancer	3.41e-06	7.49e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.4e-06	7.48e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALB—hematologic cancer	3.36e-06	7.38e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—VEGFA—hematologic cancer	3.32e-06	7.29e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—STAT3—hematologic cancer	3.28e-06	7.22e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NRAS—hematologic cancer	3.28e-06	7.2e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	3.21e-06	7.06e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KRAS—hematologic cancer	3.21e-06	7.06e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK3—hematologic cancer	3.14e-06	6.9e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MYC—hematologic cancer	3.05e-06	6.71e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TGFB1—hematologic cancer	3.04e-06	6.69e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.01e-06	6.62e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.96e-06	6.52e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	2.95e-06	6.49e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TP53—hematologic cancer	2.85e-06	6.28e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KRAS—hematologic cancer	2.82e-06	6.2e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HRAS—hematologic cancer	2.73e-06	6e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6—hematologic cancer	2.61e-06	5.74e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	2.59e-06	5.7e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTEN—hematologic cancer	2.56e-06	5.63e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.53e-06	5.56e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TP53—hematologic cancer	2.51e-06	5.51e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—EP300—hematologic cancer	2.44e-06	5.37e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKT1—hematologic cancer	2.41e-06	5.3e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HRAS—hematologic cancer	2.4e-06	5.27e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.34e-06	5.16e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6—hematologic cancer	2.29e-06	5.04e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.22e-06	4.89e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALB—hematologic cancer	2.19e-06	4.83e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKT1—hematologic cancer	2.12e-06	4.65e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.1e-06	4.62e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.94e-06	4.26e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.81e-06	3.97e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTEN—hematologic cancer	1.67e-06	3.68e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—EP300—hematologic cancer	1.6e-06	3.51e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AKT1—hematologic cancer	1.48e-06	3.25e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.18e-06	2.6e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKT1—hematologic cancer	9.65e-07	2.12e-05	CbGpPWpGaD
